OHM, thank you very much for sharing your analysis
Post# of 152576
(Total Views: 437)
Posted On: 05/07/2025 9:32:50 PM
OHM, thank you very much for sharing your analysis.
"There seems to be a couple of mistakes in that abstract." .
"The 30 month comparison is the closest long-term data we have to compare to our 4 year data. So that's .7% vs. 17.8%. In other words leronlimab is at least 25 times better very long term."
If you were going to edit the abstract to correct the errors, what would the changes be ?
"Leronlimab is at least 25 times better very long term" really caught my attention.This information is compelling and needs to shared widely.
Thank Ohm.
"There seems to be a couple of mistakes in that abstract." .
"The 30 month comparison is the closest long-term data we have to compare to our 4 year data. So that's .7% vs. 17.8%. In other words leronlimab is at least 25 times better very long term."
If you were going to edit the abstract to correct the errors, what would the changes be ?
"Leronlimab is at least 25 times better very long term" really caught my attention.This information is compelling and needs to shared widely.
Thank Ohm.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼